Looking in advance, the pharmaceutical source chain is poised for ongoing evolution and transformation driven by technological enhancements, regulatory developments, and transforming market dynamics. Numerous key developments and alternatives are likely to form the future of the pharmaceutical offer chain:Compliance with regulatory necessities and